Therapeutic Advances in Musculoskeletal Disease

SJR Rank #3,691H-index: 59SJR: 1.190Best quartile: Q1Open AccessAPC: US$2,650Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

SAGE Publications Inc.

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.30.60.91.2

Subject Categories

  • Orthopedics and Sports MedicineQ1
  • RheumatologyQ1

Areas: Medicine

Most published research topics

Rheumatoid Arthritis Research and TherapiesSpondyloarthritis Studies and TreatmentsOsteoarthritis Treatment and MechanismsBone health and osteoporosis researchSystemic Lupus Erythematosus ResearchPsoriasis: Treatment and PathogenesisAutoimmune and Inflammatory Disorders ResearchBone health and treatmentsBone Metabolism and DiseasesSystemic Sclerosis and Related Diseases

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs055110165220

Documents per Year

202220250306090120

Detailed Information

ISSN

1759-720X, 1759-7218

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

3.47

References per Document

51.98

Coverage

2009-2026

Scope

Therapeutic Advances in Musculoskeletal Disease delivers the highest quality peer-reviewed open access original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of osteoporosis and rheumatic diseases such as rheumatoid arthritis, osteoarthritis, psoriatic arthritis, ankylosing spondylitis and other related musculoskeletal diseases. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in rheumatology, osteoporosis and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area. The journal publishes review articles, original research articles, meta-analyses, systematic reviews, editorials, case reports, case series and letters to the Editor primarily. Original research manuscripts may include laboratory, animal or human/clinical studies - all phases.

Metrics from SCImago Journal Rank 2025. View on SCImago